pharmaceutical
Celgene’s COO heads to the exit
April 3, 2018Manufacturing and Production, Medical Communications, Sales and Marketing Celgene, Mark Alles, Scott Smith, biotech, drugs, pharma, pharmaceutical
Celgene has had a rough six months, its share price since the beginning of October has dropped from $146 to …
bluebird backs own CAR-T prospect, takes option to co-develop with Celgene
March 29, 2018Sales and Marketing Bluebird Bio, CAR T, CAR-T, Celgene, biotech, drugs, pharma, pharmaceutical
Biotech companies showing faith in their own prospect drug candidates is not an unusual occurrence, some do it to extremes. …
Fujifilm bolsters healthcare with two biotech buys for $800m
March 29, 2018Sales and Marketing Fujifilm, biotech, drugs, pharma, pharmaceutical
Fujifilm has made no secret of the fact it is looking to switch up part of its core business to …
Takeda moots Shire move but big questions remain
March 28, 2018Sales and Marketing Shire, Takeda, biotech, drugs, pharma, pharmaceutical
Takeda is considering making a bold move for Shire, after announcing, as per UK regulations, that it may make an …
Pfizer seeks tax breaks in return for planned $456m facility
March 28, 2018Manufacturing and Production, Research and Development Michigan, Pfizer, biotech, drugs, pharma, pharmaceutical, tax break
Pfizer has submitted proposals to officials in Portage, Michigan, for a major expansion of its manufacturing site in the city. …
May hints at providing long-term funding plan for NHS
March 28, 2018Medical Communications, Research and Development Conservatives, NHS, Theresa May, UK government, biotech, drugs, pharma, pharmaceutical
After the news broke earlier in the week of a group of nearly 100 MPs calling for a parliamentary commission …
New organ discovery has implications for cancer treatment
March 27, 2018Research and Development biotech, drugs, pharma, pharmaceutical
The discovery of an entirely new organ, the 80th to be discovered in the human body, could have serious implications …
Reaction mixed to Biohaven’s migraine drug results
March 27, 2018Manufacturing and Production, Research and Development Allergan, Biohaven, CGRP, biotech, drugs, migraine, pharma, pharmaceutical
Biohaven is full of confidence in its lead drug, rimegepant, evidenced only a few weeks ago when it decided to …
GSK to take control of Consumer Healthcare in £9.2bn buyout
March 27, 2018Manufacturing and Production, Sales and Marketing Consumer Health Care, GSK, Novartis, biotech, drugs, horlicks, pharma, pharmaceutical
GSK has announced that it plans to purchase Novartis’ 36.5% stake in the joint Consumer Healthcare Business for a sum …
Seattle Genetics gain breakthrough therapy designation
March 26, 2018Manufacturing and Production, Sales and Marketing Astellas, Seattle Genetics, biotech, drugs, pharma, pharmaceutical
Seattle Genetics and Astellas have confirmed that the drug candidate they are co-developing, enfortumab, has been given FDA breakthrough therapy …
Six reasons why UK pharma has more to gain, than fear, from Brexit
March 26, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing EMA, EU, biotech, brexit, drugs, hard Brexit, pharma, pharmaceutical
There are good reasons to think exiting the EU represents a major opportunity for this dynamic and world-leading industry, argues …
May faces pressure for cross-party talks over NHS future
March 26, 2018Medical Communications, Sales and Marketing NHS, Theresa May, UK government, biotech, drugs, pharma, pharmaceutical
A group of close to 100 MPs have demanded that Theresa May set up a parliamentary commission to plot the …
Roche’s Tecentriq improves OS in first-line lung cancer
March 26, 2018Research and Development, Sales and Marketing Roche, biotech, drugs, lung cancer, pharma, pharmaceutical, tecentriq
Roche has revealed further data from its Phase 3, IMpower150 study, which showed that a combination of Tecentriq and Avastin, …
Indivior rocked by loss of patent case
March 23, 2018Medical Communications, Sales and Marketing Alvogen, biotech, drugs, indivior, opioid, pharma, pharmaceutical
Indivior has been dealt a hammer blow after US District Court for the District of Delaware found in favour of …
Lifestyle factors to blame for 38% of cancers
March 23, 2018Medical Communications Cancer, Cancer Research UK, UK government, biotech, drugs, pharma, pharmaceutical
A new study by Cancer Research UK has found that more than 135,500 cases of cancer every year in the …
Latest content
Santen joins inaugural Global Summit for Eye Health as partner
